Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2008
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivoWilliam R Lagor, Robert J Brown, Sue-Anne Toh, et al.Journal of Lipid Research|April 5, 2012
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolismMargaret R Diffenderfer, Margaret E Brousseau, John S Millar, et al.Clinical Chemistry|April 23, 2014
Practical immunoaffinity-enrichment LC-MS for measuring protein kinetics of low-abundance proteinsMichael E Lassman, Thomas McAvoy, Anita Y H Lee, et al.Plos Genetics|September 20, 2021
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteinsSumeet A Khetarpal, Cecilia Vitali, Michael G Levin, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2005
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 productionJohn S Millar, Cyrille Maugeais, Katsunori Ikewaki, et al.Science Advances|May 16, 2025
Ppp1r3b is a metabolic switch that shifts hepatic energy storage from lipid to glycogenKate Townsend Creasy, Minal B Mehta, Carolin V Schneider, et al.Metabolism: Clinical and Experimental|March 1, 2005
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beingsJennifer L Jenner, Leo J Seman, John S Millar, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretionMargaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2006
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humansJohn S Millar, Margaret E Brousseau, Margaret R Diffenderfer, et al.Pageof 8